Tumor growth in patients with tuberous sclerosis complex on the ketogenic diet
Open Access
- 14 May 2009
- journal article
- case report
- Published by Elsevier in Brain and Development
- Vol. 32 (4) , 318-322
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Defining the Role of mTOR in CancerCancer Cell, 2007
- mTOR Complex1–S6K1 signaling: at the crossroads of obesity, diabetes and cancerTrends in Molecular Medicine, 2007
- The Tuberous Sclerosis ComplexNew England Journal of Medicine, 2006
- mTOR and cancer: insights into a complex relationshipNature Reviews Cancer, 2006
- Growing roles for the mTOR pathwayCurrent Opinion in Cell Biology, 2005
- The Tuberous Sclerosis Protein TSC2 Is Not Required for the Regulation of the Mammalian Target of Rapamycin by Amino Acids and Certain Cellular StressesJournal of Biological Chemistry, 2005
- Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype – phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis ComplexEuropean Journal of Human Genetics, 2005
- TSC2 Mediates Cellular Energy Response to Control Cell Growth and SurvivalCell, 2003
- Tsc tumour suppressor proteins antagonize amino-acid–TOR signallingNature Cell Biology, 2002
- Mutational Analysis in a Cohort of 224 Tuberous Sclerosis Patients Indicates Increased Severity of TSC2, Compared with TSC1, Disease in Multiple OrgansThe American Journal of Human Genetics, 2001